NCT06401356: An ongoing trial by Novartis Pharmaceuticals
This trial is ongoing. It must report results 2 years, 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06401356 |
|---|---|
| Title | An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 13, 2024 |
| Completion date | June 2, 2027 |
| Required reporting date | June 1, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |